{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:13:46Z","timestamp":1788390826152,"version":"build-2803163510"},"reference-count":43,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["HHSN-271-2008-00025-C"],"award-info":[{"award-number":["HHSN-271-2008-00025-C"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT077705"],"award-info":[{"award-number":["WT077705"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT083481"],"award-info":[{"award-number":["WT083481"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is an urgent need for new, brain penetrant small molecules that target the central nervous system second stage of human African trypanosomiasis (HAT). We report that a series of novel indoline-2-carboxamides have been identified as inhibitors of Trypanosoma brucei from screening of a focused protease library against Trypanosoma brucei brucei in culture. We describe the optimization and characterization of this series. Potent antiproliferative activity was observed. The series demonstrated excellent pharmacokinetic properties, full cures in a stage 1 mouse model of HAT, and a partial cure in a stage 2 mouse model of HAT. Lack of tolerability prevented delivery of a fully curative regimen in the stage 2 mouse model and thus further progress of this series.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5b00596","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T15:40:48Z","timestamp":1443541248000},"page":"7695-7706","source":"Crossref","is-referenced-by-count":28,"title":["Discovery of Indoline-2-carboxamide\nDerivatives as\na New Class of Brain-Penetrant Inhibitors of\n                    <i>Trypanosoma brucei<\/i>"],"prefix":"10.1021","volume":"58","author":[{"given":"Laura A. T.","family":"Cleghorn","sequence":"first","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se\u0301bastien","family":"Albrecht","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laste","family":"Stojanovski","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R. J.","family":"Simeons","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Norval","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kime","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain T.","family":"Collie","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"De Rycker","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Campbell","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Hallyburton","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Frearson","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Wyatt","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Read","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Gilbert","sequence":"additional","affiliation":[{"name":"University of Dundee , , Sir James Black Centre , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"2026090218181766800_cit1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related\nprotozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J.\nClin. Invest."},{"key":"2026090218181766800_cit2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2217\/fmb.11.44","article-title":"Development of novel\ndrugs for human African trypanosomiasis","volume":"6","author":"Brun","year":"2011","journal-title":"Future\nMicrobiol."},{"key":"2026090218181766800_cit3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/bmb\/lds031","article-title":"Management\nof trypanosomiasis and leishmaniasis","volume":"104","author":"Barrett","year":"2012","journal-title":"Br. Med.\nBull."},{"key":"2026090218181766800_cit4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1042\/BJ20090283","article-title":"Drug Screening\nby crossing membranes: a novel approach to identification of trypanocides","volume":"419","author":"Field","year":"2009","journal-title":"Biochem. J."},{"key":"2026090218181766800_cit5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1472-8206.2003.00167.x","article-title":"Treatment perspectives\nfor human African trypanosomiasis","volume":"17","author":"Bouteille","year":"2003","journal-title":"Fundam. Clin.\nPharmacol."},{"key":"2026090218181766800_cit6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis:\npharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"2026090218181766800_cit7","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.2174\/092986710793205345","article-title":"The Kinetoplastid\nchemotherapy revisited: current drugs, recent advances and future\nperspectives","volume":"17","author":"Castillo","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"2026090218181766800_cit8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination\ntherapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised,\nphase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"2026090218181766800_cit9","doi-asserted-by":"publisher","first-page":"e720","DOI":"10.1371\/journal.pntd.0000720","article-title":"NECT is next:\nimplementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness","volume":"4","author":"Yun","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"2026090218181766800_cit10","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1128\/AAC.00332-10","article-title":"Cross-resistance\nto nitro drugs and implications for\ntreatment of human African trypanosomiasis","volume":"54","author":"Sokolova","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090218181766800_cit11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/DDDT.S16381","article-title":"Drug discovery and development for neglected diseases:\nthe DNDi model","volume":"5","author":"Chatelain","year":"2011","journal-title":"Drug Des., Dev. Ther."},{"key":"2026090218181766800_cit12","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.bcp.2010.07.038","article-title":"Identification\nof a k-opioid agonist as a potent and\nselective lead for drug development against human African trypanosomiasis","volume":"80","author":"Jones","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"2026090218181766800_cit13","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/cmdc.201100278","article-title":"Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488","volume":"6","author":"Smith","year":"2011","journal-title":"ChemMedChem"},{"key":"2026090218181766800_cit14","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1021\/jm400362b","article-title":"Drug discovery\nfor neglected diseases: Molecular target-based and phenotypic approaches","volume":"56","author":"Gilbert","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090218181766800_cit15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from\nassembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"key":"2026090218181766800_cit16","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1023\/A:1015040217741","article-title":"Polar molecular surface as a dominating determinant\nfor oral absorption and brain penetration of drugs","volume":"16","author":"Kelder","year":"1999","journal-title":"Pharm. Res."},{"key":"2026090218181766800_cit17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/cn100007x","article-title":"Defining desirable Central Nervous\nSystem drug space through the alignment of molecular properties, in\nvitro ADME, and safety attributes","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem.\nNeurosci."},{"key":"2026090218181766800_cit18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: The development\nof a Central Nervous System Multiparameter Optimization (CNS MPO)\napproach to enable aignment of drug-like properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"2026090218181766800_cit19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1017\/S0031182013001017","article-title":"Target-based\ndrug discovery for human African trypanosomiasis: selection of molecular\ntarget and chemical matter","volume":"141","author":"Gilbert","year":"2014","journal-title":"Parasitology"},{"key":"2026090218181766800_cit20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/0471264229.os084.26","article-title":"Preparation\nof substituted 5-azaindoles:\nMety 4-chloro-1H-pyrrolo[3,2-C]pyridine-2-carboxylate","volume":"84","author":"Roy","year":"2007","journal-title":"Org. Synth."},{"key":"2026090218181766800_cit21","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1021\/ja072219k","article-title":"Intramolecular\nC-H aminations reactions: Exploitation of the Rh-2(II)-Catalysed decomposition\nof azidoacrylates","volume":"129","author":"Stokes","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"2026090218181766800_cit22","first-page":"434","article-title":"Reduction of indole-2-carboxylate\nand 2-carboxamide with magnesium\nin methanol","volume":"8","author":"Youn","year":"1987","journal-title":"Bull. Korean Chem. Soc."},{"key":"2026090218181766800_cit23","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.tetlet.2003.12.102","article-title":"Highly enantioselective\nalkylation\nof glycine methyl and ethyl ester derivatives under phase-transfer\ncondiditons: it synthetic advantage","volume":"45","author":"Ooi","year":"2004","journal-title":"Tetrahedron\nLett."},{"key":"2026090218181766800_cit24","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/j.tetlet.2008.01.029","article-title":"Combinatorial approach\nfor the design of new, simplified chiral phase-transfer catalysts\nwith high catalytic performance for practical asymmetric synthesis\nof alpha-alkyl-alpha-amino acids","volume":"49","author":"Kitamura","year":"2008","journal-title":"Tetrahedron\nLett."},{"key":"2026090218181766800_cit25","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1021\/ja021244h","article-title":"Design of N-spiro C-2-symmetric chiral\nquaternary ammonium bromides as novel chiral phase-transfer catalysts:\nSynthesis and application to practical asymmetric synthesis of alpha-amino\nacids","volume":"125","author":"Ooi","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"2026090218181766800_cit26","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.tetasy.2008.06.010","article-title":"Efficient access to enantiomerically\npure cyclic alpha-amino esters\nthrough a lipase-catalyzed kinetic resolution","volume":"19","author":"Alatorre-Santamaria","year":"2008","journal-title":"Tetrahedron: Asymmetry"},{"key":"2026090218181766800_cit27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1021\/jm201091t","article-title":"Discovery\nof a novel class of orally active trypanocidal N-myristoyltransferase\ninhibitors","volume":"55","author":"Brand","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026090218181766800_cit28","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Synopsis\nof some recent tactical application of bioisosteres in drug design","volume":"54","author":"Meanwell","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026090218181766800_cit29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/cbic.200301023","article-title":"Fluorine in medicinal\nchemistry","volume":"5","author":"Bo\u0308hm","year":"2004","journal-title":"ChemBioChem"},{"key":"2026090218181766800_cit30","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1021\/ja981045r","article-title":"A palladium-catalyzed\nstrategy for\nthe preparation of indoles: a novel entry into the Fischer indole\nsynthesis","volume":"120","author":"Wagaw","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"2026090218181766800_cit31","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-04-4103","article-title":"Role of hepatic\ncytochrome P450s in the pharmacokinetics and toxicity of cyclophosphamide:\nStudies with the hepatic cytochrome P450 reductase null mouse","volume":"65","author":"Pass","year":"2005","journal-title":"Cancer Res."},{"key":"2026090218181766800_cit32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase\ninhibitors as new leads to treat sleeping sickness","volume":"464","author":"Frearson","year":"2010","journal-title":"Nature"},{"key":"2026090218181766800_cit33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0065-308X(06)63002-9","article-title":"Targeting of toxic compounds to the trypanosomes","volume":"63","author":"Barrett","year":"2006","journal-title":"Adv. Parasitol."},{"key":"2026090218181766800_cit34","doi-asserted-by":"publisher","first-page":"e1932","DOI":"10.1371\/journal.pntd.0001932","article-title":"A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for\nprogression into drug discovery programmes","volume":"6","author":"De Rycker","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"2026090218181766800_cit35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0035-9203(83)90207-9","article-title":"Treatment with suranim\nand 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei infections with central nervous\nsystem involvement","volume":"77","author":"Jennings","year":"1983","journal-title":"Trans. R. Soc. Trop. Med.\nHyg."},{"key":"2026090218181766800_cit36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2174\/138620708784911483","article-title":"Massively parallel screening of the receptorome","volume":"11","author":"Jensen","year":"2008","journal-title":"Comb. Chem. High Throughput Screening"},{"key":"2026090218181766800_cit37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological\nprofiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"2026090218181766800_cit38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2174\/156802611795429176","article-title":"Finding\nnew hits in neglected disease\nprojects: Target or phenotypic based screening?","volume":"11","author":"Gilbert","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"2026090218181766800_cit39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar\nBlue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense)\nin vitro","volume":"68","author":"Raz","year":"1997","journal-title":"Acta Trop."},{"key":"2026090218181766800_cit40","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1128\/AAC.00722-13","article-title":"The R enantiomer\nof the antitubercular\ndrug PA-824 as a potential oral treatment for visceral Leishmaniasis","volume":"57","author":"Patterson","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090218181766800_cit41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition:\nthe relationship\nbetween in situ brain permeability and brain free fraction","volume":"322","author":"Summerfield","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026090218181766800_cit42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/bdd.325","article-title":"Influence of nonspecific\nbrain and plasma binding on\nCNS exposure: implications for rational drug discovery","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm. Drug Dispos."},{"key":"2026090218181766800_cit43","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-3565(24)36870-3","article-title":"Prediction of in vivo hepatic metabolic clearance of\nYM796 from in vitro data by use of human liver microsomes and recombinant\nP-450 isozymes","volume":"282","author":"Iwatsubo","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5b00596","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/58\/19\/7695\/67032742\/acs.jmedchem.5b00596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/58\/19\/7695\/67032742\/acs.jmedchem.5b00596.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:19:00Z","timestamp":1788387540000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/58\/19\/7695\/1451037\/Discovery-of-Indoline-2-carboxamide-Derivatives-as"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":43,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2015,9,29]]},"published-print":{"date-parts":[[2015,10,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00596","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]}}}